InvestorsHub Logo
Followers 79
Posts 24611
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 03/26/2024 8:58:34 AM

Tuesday, March 26, 2024 8:58:34 AM

Post# of 27525
VKTX - 69.19 Pre-market at 80.71/81

Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.